Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Mem. Inst. Oswaldo Cruz ; 111(3): 161-167, Mar. 2016. tab, graf
Article in English | LILACS | ID: lil-777371

ABSTRACT

Severe dengue pathogenesis is not fully understood, but high levels of proinflammatory cytokines have been associated with dengue disease severity. In this study, the cytokine levels in 171 sera from Mexican patients with primary dengue fever (DF) and dengue haemorrhagic fever (DHF) from dengue virus (DENV) 1 (n = 116) or 2 (n = 55) were compared. DF and DHF were defined according to the patient’s clinical condition, the primary infections as indicated by IgG enzymatic immunoassay negative results, and the infecting serotype as assessed by real-time reverse transcription-polymerase chain reaction. Samples were analysed for circulating levels of interleukin (IL)-12p70, interferon (IFN)-γ, tumour necrosis factor (TNF)-α, IL-6, and IL-8 using a commercial cytometric bead array. Significantly higher IFN-γ levels were found in patients with DHF than those with DF. However, significantly higher IL-12p70, TNF-α, and IL-6 levels were associated with DHF only in patients who were infected with DENV2 but not with DENV1. Moreover, patients with DF who were infected with DENV1 showed higher levels of IL-12p70, TNF-α, and IL-6 than patients with DHF early after-fever onset. The IL-8 levels were similar in all cases regardless of the clinical condition or infection serotype. These results suggest that the association between high proinflammatory cytokine levels and dengue disease severity does not always stand, and it once again highlights the complex nature of DHF pathogenesis.


Subject(s)
Female , Humans , Male , Cytokines/metabolism , Dengue Virus/immunology , Severe Dengue/immunology , Dengue Virus/classification , Dengue/immunology , Enzyme-Linked Immunosorbent Assay , Inflammation Mediators/metabolism , Interferon-gamma/blood , /blood , /blood , /blood , Mexico , Real-Time Polymerase Chain Reaction/methods , Serogroup , Statistics, Nonparametric , Severe Dengue/blood , Tumor Necrosis Factor-alpha/blood
2.
Salud pública Méx ; 42(5): 431-7, sept.-oct. 2000. tab, CD-ROM
Article in Spanish | LILACS | ID: lil-280323

ABSTRACT

Objetivo. Medir la tasa de incidencia de las leucemias agudas (LA) en las diferentes delegaciones políticas del Distrito Federal y evaluar si existe una tendencia significativa en dichos padecimientos en tales delegaciones. Material y métodos. Estudio longitudinal descriptivo realizado en seis hospitales de la ciudad de México, los que atienden a cerca de 97.5 por ciento de todos los niños con cáncer de esta ciudad. Los datos se capturaron de 1995 a 1996, y se analizaron en 1999, en el Hospital de Pediatría del Centro Médico Nacional Siglo XXI, del Instituto Mexicano del Seguro Social. Para cada delegación se cal-cularon la tasa de incidencia anual promedio, la tasa es-tandarizada y la razón estandarizada de morbilidad (REM) con intervalos de confianza al 95 por ciento (IC 95 por ciento). La tendencia se evaluó con la tasa de cambio promedio. Re-sultados. Se observó una tendencia al incremento en la incidencia de la leucemia aguda linfoblástica (LAL) en cinco delegaciones: Alvaro Obregón, Cuauhtémoc, Gustavo A. Madero, Izta-calco y Venustiano Carranza. En la leucemia aguda mieloblás-tica (LAM) no se notificaron cambios estadísticamente signi-ficativos en la incidencia en ninguna delegación política. Sólo con LAM se encontró una REM significativa y co-rrespondió a la delegación Alvaro Obregón (REM= 2.91, IC 95 por ciento 1.63 - 4.80). Las REM más altas se encontraron en el sur y suroeste de la ciudad. Conclusiones. Sólo se observó incremento en la incidencia de LAL en cinco delegaciones políticas. La incidencia más alta de LAM se encontró en la delegación Alvaro Obregón.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Adolescent , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/epidemiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality , Mexico/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL